Emerald Advisers, LLC
- SEC CIK
- 0001015083
- Latest filing
- Aug 5, 2026
DXCM holding history
Dexcom Inc in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −2,107−100.0% | Sold out | Holders |
| Q4 2023 | 2,107 | $261.5K | <0.1% | −28−1.3% | Reduced | Holders |
| Q3 2023 | 2,135 | $199.2K | <0.1% | −46−2.1% | Reduced | Holders |
| Q2 2023 | 2,181 | $280.3K | <0.1% | −31−1.4% | Reduced | Holders |
| Q1 2023 | 2,212 | $257.0K | <0.1% | −2,452−52.6% | Reduced | Holders |
| Q4 2022 | 4,664 | $528.2K | <0.1% | −79−1.7% | Reduced | Holders |
| Q3 2022 | 4,743 | $382.0K | <0.1% | −37−0.8% | Reduced | Holders |
| Q2 2022 | 4,780 | $356.0K | <0.1% | 00.0% | UnchangedConverted for a 4-for-1 split | Holders |
| Q1 2022 | 1,195 | $611.0K | <0.1% | −23−1.9% | Reduced | Holders |
| Q4 2021 | 1,218 | $654.0K | <0.1% | −719−37.1% | Reduced | Holders |
| Q3 2021 | 1,937 | $1.06M | <0.1% | +450+30.3% | Added | Holders |
| Q2 2021 | 1,487 | $635.0K | <0.1% | +1,487 | New | Holders |